Myo-inositol in the treatment of premenstrual dysphoric disorder.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/22031267
Conclusion of this study
In the present study, by using a new pharmaceutical formulation, we were able to clearly prove the efficacy of myo-inositol in PMDD.
Supplements analyzed in this study
|
Health conditions analyzed in this study
|
||
|
||
|
||
|
Functions related to this study
|
||
|
||
|
||
|
Body systems related to this study
Nervous System |
Reproductive System |